Chanakya Nath Kundu (Chanakya N Kundu, Christian Knackstedt)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Cancer Stem Cells

Heat Shock Protein

Top Venues

Medical oncology (Northwood, London, England)

Nanomedicine (London, England)

Journal of molecular modeling

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Vajja Krishna Rao, Subarno Paul, Mitchell Gulkis, Zhihang Shen, Haritha Nair, Amandeep Singh, Chenglong Li, Arun K Sharma, Melike Çağlayan, Chinmay Das, Biswajit Das, Chanakya Nath Kundu, Satya Narayan, Sankar K Guchhait
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents. RSC medicinal chemistry 15 (3) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Vajja Krishna Rao, Subarno Paul, Mitchell Gulkis, Zhihang Shen, Haritha Nair, Amandeep Singh, Chenglong Li, Arun K Sharma, Melike Çağlayan, Chinmay Das, Biswajit Das, Chanakya Nath Kundu, Satya Narayan, Sankar K Guchhait
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents. RSC medicinal chemistry 15 (3) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) 19 (7) (2024)
Vajja Krishna Rao, Subarno Paul, Mitchell Gulkis, Zhihang Shen, Haritha Nair, Amandeep Singh, Chenglong Li, Arun K Sharma, Melike Çağlayan, Chinmay Das, Biswajit Das, Chanakya Nath Kundu, Satya Narayan, Sankar K Guchhait
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents. RSC medicinal chemistry 15 (3) (2024)
Somya Ranjan Dash, Chinmay Das, Biswajit Das, Atala Bihari Jena, Subarno Paul, Saptarshi Sinha, Jasaswini Tripathy, Chanakya Nath Kundu
Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (London, England) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Somya Ranjan Dash, Chanakya Nath Kundu
Advances in nanomedicine for the treatment of infectious diseases caused by viruses. Biomaterials science (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Chinmay Das, Somya Ranjan Dash, Saptarshi Sinha, Subarno Paul, Biswajit Das, Subhasmita Bhal, Chinmayee Sethy, Chanakya Nath Kundu
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300. Medical oncology (Northwood, London, England) 40 (12) (2023)
Chanakya Nath Kundu, Georg Schummers, Jörg Schröder, Nikolaus Marx, Joost Lumens, Sandra Sanders-van Wijk, Bram Ramaekers, Michael Becker, Vanessa van Empel, Hans-Peter Brunner-La Rocca, null null
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function. The international journal of cardiovascular imaging (2023)
Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, Somya Ranjan Dash, Saptarshi Sinha, Subarno Paul, Kunal Goutam, Chanakya Nath Kundu
Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells. Journal of cell communication and signaling (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Somya Ranjan Dash, Biswajit Das, Chinmay Das, Saptarshi Sinha, Subarno Paul, Rajalaxmi Pradhan, Chanakya Nath Kundu
Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β. Nanomedicine (London, England) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Deepika Nayak, Subarno Paul, Chinmay Das, Subhasmita Bhal, Chanakya Nath Kundu
Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A. Journal of cell communication and signaling (2022)
Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, Saptarshi Sinha, Biswajit Das, Somya Ranjan Dash, Chanakya Nath Kundu
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping. Journal of cancer research and clinical oncology 148 (12) (2022)
Saptarshi Sinha, Sefinew Molla, Chanakya Nath Kundu
PARP1-modulated chromatin remodeling is a new target for cancer treatment. Medical oncology (Northwood, London, England) 38 (10) (2021)
Saptarshi Sinha, Chanakya Nath Kundu
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Medical oncology (Northwood, London, England) 38 (9) (2021)
Shakti Ranjan Satapathy, Sumit Siddharth, Dipon Das, Anmada Nayak, Chanakya Nath Kundu
Correction to "Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade". Molecular pharmaceutics 17 (8) (2020)
Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy, Deepika Nayak, Rajalaxmi Pradhan, Sefinew Molla, Birendra Kumar Bindhani, Chanakya Nath Kundu
Correction to "Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer". Molecular pharmaceutics 17 (8) (2020)
Krushna Chandra Hembram, Somya Ranjan Dash, Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee, Birendra Kumar Bindhani, Chanakya Nath Kundu
Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells. Molecular pharmaceutics 17 (7) (2020)
Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy, Deepika Nayak, Rajalaxmi Pradhan, Sefinew Molla, Birendra Kumar Bindhani, Chanakya Nath Kundu
Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer. Molecular pharmaceutics 16 (7) (2019)
Chinmayee Sethy, Kunal Goutam, Deepika Nayak, Rajalaxmi Pradhan, Sefinew Molla, Subhajit Chatterjee, Niranjan Rout, Michael D Wyatt, Satya Narayan, Chanakya Nath Kundu
Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse. Journal of cancer research and clinical oncology 146 (1) (2019)